CXCR3 and HIV infectious disease: Furthermore, when CXCR3 and CCR5 act as the virus cellular co-receptor, CXCR3 and CCR5 antagonists have been used in the treatment of HIV infection in clinical practice [32], indicating the modulation of the CXCR3 and CCR5 pathway might be a potential therapeutic strategy.